Joint ( (JYNT) ) just unveiled an update.
On March 10, 2025, The Joint Corp.’s Board of Directors approved an amendment to the Executive Short-Term Incentive Plan, linking executive bonuses to adjusted EBITDA performance. The company reported a 14% revenue increase for Q4 2024, with net income of $986,000 from continuing operations, marking a significant improvement from a $10.2 million loss in Q4 2023. The Joint Corp. plans to focus on refranchising and enhancing digital marketing to drive growth in 2025, with expectations of increased clinic openings and sales in 2026.
More about Joint
The Joint Corp. is a national operator, manager, and franchisor of chiropractic clinics, focused on providing chiropractic care through an asset-light franchise model. The company aims to strengthen its position as a leading chiropractic care provider by enhancing its core operations, expanding its market presence, and improving profitability.
YTD Price Performance: 0.86%
Average Trading Volume: 41,043
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $157.2M
See more insights into JYNT stock on TipRanks’ Stock Analysis page.